Rosenberg; Saul H.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rosenberg; Saul H..The latest application filed is for "companion diagnostic assays for cancer therapy".
- Rosenberg; Saul H. - Grayslake IL
- Rosenberg; Saul H. - Libertyville IL
| Patent | Date |
|---|---|
| Companion Diagnostic Assays For Cancer Therapy App 20100028889 - Anderson; Mark G. ; et al. | 2010-02-04 |
| N-acylsulfonamide Apoptosis Promoters App 20090137585 - Augeri; David J. ; et al. | 2009-05-28 |
| N-acylsulfonamide apoptosis promoters Grant 7,504,512 - Augeri , et al. March 17, 2 | 2009-03-17 |
| Continuous Dosing Regimen App 20070197607 - Gordon; Gary ; et al. | 2007-08-23 |
| Continuous Dosing Regimen App 20070191437 - Gordon; Gary ; et al. | 2007-08-16 |
| Treatment of cancer in pediatric patients App 20060089391 - Gordon; Gary ; et al. | 2006-04-27 |
| Continuous dosing regimen App 20050267166 - Gordon, Gary ; et al. | 2005-12-01 |
| Continuous dosing regimen App 20050075395 - Gordon, Gary ; et al. | 2005-04-07 |
| Kinase inhibitors Grant 6,831,175 - Li , et al. December 14, 2 | 2004-12-14 |
| N-acylsulfonamide apoptosis promoters App 20040192681 - Augeri, David J. ; et al. | 2004-09-30 |
| N-acylsulfonamide apoptosis promoters Grant 6,720,338 - Augeri , et al. April 13, 2 | 2004-04-13 |
| Inhibitors of protein isoprenyl transferases Grant 6,693,123 - Sebti , et al. February 17, 2 | 2004-02-17 |
| Kinase inhibitors App 20030199511 - Li, Qun ; et al. | 2003-10-23 |
| Kinase inhibitors App 20030187026 - Li, Qun ; et al. | 2003-10-02 |
| Inhibitors of protein isoprenyl transferases App 20020193596 - Sebti, Said M. ; et al. | 2002-12-19 |
| N-Acylsulfonamide apoptosis promoters App 20020086887 - Augeri, David J. ; et al. | 2002-07-04 |
| N-acylsulfonamide apoptosis promoters App 20020055631 - Augeri, David J. ; et al. | 2002-05-09 |
| Inhibitors of protein isoprenyl transferases Grant 6,310,095 - Sebti , et al. October 30, 2 | 2001-10-30 |
| Inhibitors of protein isoprenyl transferases Grant 6,204,293 - Sebti , et al. March 20, 2 | 2001-03-20 |
| Inhibitors of protein farnesyltransferase and squalene synthase Grant 5,631,401 - Stein , et al. May 20, 1 | 1997-05-20 |
| Renin inhibitors Grant 5,332,742 - Rosenberg July 26, 1 | 1994-07-26 |
| Angiotensin II receptor antagonists Grant 5,326,776 - Winn , et al. July 5, 1 | 1994-07-05 |
| Angiotensin II receptor antagonists Grant 5,250,548 - Winn , et al. October 5, 1 | 1993-10-05 |
| Heterocyclic peptide renin inhibitors Grant 5,164,388 - De , et al. November 17, 1 | 1992-11-17 |
| Peptidyl aminodiol renin inhibitors Grant 5,063,208 - Rosenberg , et al. November 5, 1 | 1991-11-05 |
| Heterocyclic renin inhibitors Grant 4,994,477 - Kempf , et al. February 19, 1 | 1991-02-19 |
| Functionalized peptidyl aminodiols and -triols 4-amino-5-cyclohexyl-3-hydroxy-1,2-oxopentane and derivatives thereof Grant 4,977,277 - Rosenberg , et al. December 11, 1 | 1990-12-11 |
| Angiotensinogen analogs Grant 4,857,507 - Rosenberg , et al. * August 15, 1 | 1989-08-15 |
| Functionalized peptidyl aminodiols and -triols Grant 4,837,204 - Rosenberg , et al. June 6, 1 | 1989-06-06 |
| Renin inhibiting compounds Grant 4,826,815 - Luly , et al. May 2, 1 | 1989-05-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 